Lido Advisors
BIO icon

Lido Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Lido Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
+808
New +$233K ﹤0.01% 1721
2025
Q1 		– Sell
-757
Closed -$249K – 1528
2024
Q4 		$249K Sell
757
-15
-2% -$5.09K ﹤0.01% 1299
2024
Q3 		$258K Buy
772
+24
+3% +$7.62K ﹤0.01% 1220
2024
Q2 		$204K Sell
748
-721
-49% -$210K ﹤0.01% 1281
2024
Q1 		$508K Sell
1,469
-603
-29% -$198K ﹤0.01% 898
2023
Q4 		$669K Buy
2,072
+842
+68% +$264K 0.01% 752
2023
Q3 		$441K Buy
1,230
+411
+50% +$159K ﹤0.01% 783
2023
Q2 		$310K Buy
+819
New +$333K ﹤0.01% 916

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return